Cost Savings Associated with Detection and Treatment of Diabetic Eye Disease
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (Supplement) , 33-39
- https://doi.org/10.2165/00019053-199500081-00008
Abstract
Objective: Diabetic retinopathy, which leads to macular oedema and retinal neovascularisation, is the leading cause of blindness among working age Americans. Research has demonstrated significant...Keywords
This publication has 29 references indexed in Scilit:
- Preventive Eye Care in People With Diabetes Is Cost-Saving to the Federal Government: Implications for health-care reformDiabetes Care, 1994
- Discounting health care: only a matter of timing?The Lancet, 1992
- Discounting and health benefitsHealth Economics, 1992
- On the Discounting of Gained life-Years in Cost-Effectiveness AnalysisInternational Journal of Technology Assessment in Health Care, 1992
- Cost-Effectiveness of the Screening and Treatment of Diabetic Retinopathy:What Are the Costs of Underutilization?International Journal of Technology Assessment in Health Care, 1992
- Fifteen-year Argon Laser and Xenon Photocoagulation Results of Bascom Palmer Eye Institute's Patients Participating in the Diabetic Retinopathy StudyOphthalmology, 1991
- Cost-Effectiveness of Strategies for Detecting Diabetic RetinopathyMedical Care, 1991
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- Cost-Effectiveness of Interventions to Prevent or Treat Coronary Heart DiseaseAnnual Review of Public Health, 1985
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977